GenMont Biotech Incorporation (TPE:3164)
17.95
-0.05 (-0.28%)
Mar 24, 2026, 1:30 PM CST
TPE:3164 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 103.73 | 110.51 | 55.6 | 133.69 | 169.95 |
Short-Term Investments | 261.62 | 248.13 | 272.71 | 267.26 | 251.78 |
Cash & Short-Term Investments | 365.36 | 358.64 | 328.3 | 400.94 | 421.73 |
Cash Growth | 1.87% | 9.24% | -18.12% | -4.93% | -9.33% |
Accounts Receivable | 46.16 | 31.6 | 38.23 | 50.36 | 54.01 |
Other Receivables | 0.74 | 1.73 | 1.79 | 1.4 | 1.05 |
Receivables | 46.89 | 33.33 | 40.02 | 51.76 | 55.06 |
Inventory | 70.39 | 77.67 | 88.12 | 55.3 | 37.06 |
Prepaid Expenses | 5.23 | 4.92 | 9.07 | 13.49 | 66.94 |
Other Current Assets | 67.44 | 67.17 | - | - | - |
Total Current Assets | 555.31 | 541.73 | 465.51 | 521.5 | 580.79 |
Property, Plant & Equipment | 976.29 | 1,037 | 1,060 | 1,113 | 1,045 |
Long-Term Investments | - | 6.09 | 7.32 | 26.52 | 34.68 |
Other Intangible Assets | 2.01 | 2.16 | 2.26 | 0.24 | 0.33 |
Long-Term Deferred Tax Assets | 51.84 | 42.04 | 39.7 | 22.73 | 12.31 |
Other Long-Term Assets | 79.64 | 79.89 | 78.29 | 11.59 | 24.8 |
Total Assets | 1,665 | 1,709 | 1,653 | 1,696 | 1,698 |
Accounts Payable | 8.14 | 6.3 | 7.85 | 14.37 | 11.39 |
Short-Term Debt | 23.5 | 20.48 | - | - | - |
Current Portion of Long-Term Debt | 8.89 | 12.24 | 2.24 | - | - |
Current Portion of Leases | 1.76 | 2.4 | 2.36 | 1.06 | 2.11 |
Current Income Taxes Payable | 22.74 | 12.19 | 18.95 | 28.44 | 33.82 |
Current Unearned Revenue | 22.04 | 40.05 | 33.98 | 25.76 | 25.33 |
Other Current Liabilities | 42.72 | 46.48 | 81.01 | 91.16 | 66.51 |
Total Current Liabilities | 129.78 | 140.15 | 146.39 | 160.78 | 139.17 |
Long-Term Debt | 44.9 | 49.23 | 20.11 | - | - |
Long-Term Leases | 32.84 | 34.26 | 33.6 | 33.49 | 30.62 |
Long-Term Deferred Tax Liabilities | 5.52 | 3.11 | 1.59 | 1.96 | 1.54 |
Other Long-Term Liabilities | 2.32 | 2.32 | 2.37 | 2.37 | 2.32 |
Total Liabilities | 215.35 | 229.07 | 204.06 | 198.59 | 173.65 |
Common Stock | 860.1 | 865.11 | 865.11 | 863.71 | 863.71 |
Additional Paid-In Capital | 351.77 | 353.74 | 377.1 | 375.69 | 375.69 |
Retained Earnings | 113.34 | 128.02 | 89.97 | 117.5 | 154.87 |
Comprehensive Income & Other | 5.66 | 4.9 | -15.88 | -5.58 | -17.83 |
Total Common Equity | 1,331 | 1,352 | 1,316 | 1,351 | 1,376 |
Minority Interest | 118.85 | 127.9 | 132.82 | 145.89 | 147.95 |
Shareholders' Equity | 1,450 | 1,480 | 1,449 | 1,497 | 1,524 |
Total Liabilities & Equity | 1,665 | 1,709 | 1,653 | 1,696 | 1,698 |
Total Debt | 111.88 | 118.61 | 58.31 | 34.55 | 32.73 |
Net Cash (Debt) | 253.47 | 240.03 | 270 | 366.4 | 389 |
Net Cash Growth | 5.60% | -11.10% | -26.31% | -5.81% | -9.70% |
Net Cash Per Share | 2.92 | 2.77 | 3.12 | 4.23 | 4.48 |
Filing Date Shares Outstanding | 87.6 | 86.51 | 86.51 | 86.37 | 86.37 |
Total Common Shares Outstanding | 87.6 | 86.51 | 86.51 | 86.37 | 86.37 |
Working Capital | 425.53 | 401.59 | 319.12 | 360.73 | 441.62 |
Book Value Per Share | 15.19 | 15.63 | 15.22 | 15.65 | 15.94 |
Tangible Book Value | 1,329 | 1,350 | 1,314 | 1,351 | 1,376 |
Tangible Book Value Per Share | 15.17 | 15.60 | 15.19 | 15.64 | 15.93 |
Buildings | - | 923.19 | 886.14 | 877.91 | 168.74 |
Machinery | - | 489.48 | 481.71 | 419.15 | 234.11 |
Construction In Progress | - | 0.02 | 0.03 | 75.24 | 858.62 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.